Security key
00288U106
AbCellera Biologics Inc. - Common Shares, no par value per share (ABCL)
CUSIP: 00288U106
Q3 2025 13F Holders as of 30 Sep 2025
- Security type / class
- Equity / Common Shares, no par value per share
- Total 13F shares
- 104,032,627
- Total 13F value
- $524,646,193
- Share change
- -3,738,353
- Put/Call ratio
- 68%
- SEC-reported price per share
- $5.03
- Number of holders
- 140
- Value change
- +$3,617,959
- Number of buys
- 76
- Number of sells
- 57
- Shares outstanding
- 305,667,944
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2025
Institutions
140
Top holders
10
ABCL full security history
Ownership snapshot
Full 13F holder table
AbCellera Biologics Inc. SEC filings
AbCellera Biologics Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of ABCL - AbCellera Biologics Inc. - Common Shares, no par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BAILLIE GIFFORD & CO
Disclosed value leader
BAKER BROS. ADVISORS LP
Comparable rows
15/15
Latest evidence
30 Jun 2025
13F
13D/G
Lead comparable stake: 4.4%
13D/G row: BAILLIE GIFFORD & CO
Showing 1-6 of 15 holder rows.
Quick read
BAILLIE GIFFORD & CO leads the comparable SEC ownership view at 4.4%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BAILLIE GIFFORD & CO's linked filing trail.
Comparable ownership
Top 5
BAILLIE GIFFORD & CO
4.4%
BAKER BROS. ADVISORS LP
9%
Capital World Investors
4.4%
UBS AM, a distinct business unit ...
2.8%
TWO SIGMA INVESTMENTS, LP
1.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BAILLIE GIFFORD & CO |
13F
13D/G
Company
|
4.4%
from 13D/G
|
$35,534,813
10,360,004 shares
|
— | 30 Jun 2025 |
| BAKER BROS. ADVISORS LP |
13F
Company
|
9%
|
$94,412,945
27,525,640 shares
|
— | 30 Jun 2025 |
| Capital World Investors |
13F
Company
|
4.4%
|
$45,828,559
13,361,096 shares
|
— | 30 Jun 2025 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
Company
|
2.8%
|
$29,057,653
8,471,619 shares
|
— | 30 Jun 2025 |
| TWO SIGMA INVESTMENTS, LP |
13F
Company
|
1.3%
|
$14,100,222
4,110,852 shares
|
— | 30 Jun 2025 |
| ArrowMark Colorado Holdings LLC |
13F
Company
|
1.3%
|
$14,080,476
4,105,095 shares
|
— | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
140
Shares
104,032,627
Rows available
140
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
127
Q3 2025 holders
140
Holder diff
13
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|